Bio-Techne Corporation
-
Pharma
Merck to acquire Bio-Techne in $11.3 billion deal to expand life sciences business
The proposed acquisition will strengthen Merck’s presence in areas including multi-omics, spatial biology and cell and gene therapy, subject to…
Read More »